Progress in Structure Based Drug Design for G Protein-Coupled Receptors

被引:157
作者
Congreve, Miles [1 ]
Langmead, Christopher J. [1 ]
Mason, Jonathan S. [1 ]
Marshall, Fiona H. [1 ]
机构
[1] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England
关键词
SITE-DIRECTED MUTAGENESIS; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; BINDING-SITE; ALLOSTERIC MODULATION; PHARMACOLOGICAL CHARACTERIZATION; BETA(2)-ADRENERGIC RECEPTOR; ADENOSINE RECEPTORS; IN-SILICO; MOLECULAR RECOGNITION;
D O I
10.1021/jm200371q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:4283 / 4311
页数:29
相关论文
共 185 条
[31]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF CHEMOKINES [J].
CLARKLEWIS, I ;
KIM, KS ;
RAJARATHNAM, K ;
GONG, JH ;
DEWALD, B ;
MOSER, B ;
BAGGIOLINI, M ;
SYKES, BD .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (05) :703-711
[32]   Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a New Scaffold To Develop Potent and Selective Human A3 Adenosine Receptor Antagonists. Synthesis, Pharmacological Evaluation, and Ligand-Receptor Modeling Studies [J].
Colotta, Vittoria ;
Lenzi, Ombretta ;
Catarzi, Daniela ;
Varano, Flavia ;
Filacchioni, Guido ;
Martini, Claudia ;
Trincavelli, Letizia ;
Ciampi, Osele ;
Pugliese, Anna Maria ;
Traini, Chiara ;
Pedata, Felicita ;
Morizzo, Erika ;
Moro, Stefano .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) :2407-2419
[33]   Recent developments in fragment-based drug discovery [J].
Congreve, Miles ;
Chessari, Gianni ;
Tisi, Dominic ;
Woodhead, Andrew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3661-3680
[34]   FRAGMENT SCREENING OF STABILIZED 6-PROTEIN-COUPLED RECEPTORS USING BIOPHYSICAL METHODS [J].
Congreve, Miles ;
Rich, Rebecca L. ;
Myszka, David G. ;
Figaroa, Francis ;
Siegal, Gregg ;
Marshall, Fiona H. .
FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 :115-136
[35]   Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders [J].
Conn, P. Jeffrey ;
Christopoulos, Arthur ;
Lindsley, Craig W. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :41-54
[36]   Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders [J].
Conn, P. Jeffrey ;
Jones, Carrie K. ;
Lindsley, Craig W. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (03) :148-155
[37]   Architecture of P2Y nucleotide receptors: Structural comparison based on sequence analysis, mutagenesis, and homology modeling [J].
Costanzi, S ;
Mamedova, L ;
Gao, ZG ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) :5393-5404
[38]   On the applicability of GPCR homology models to computer-aided drug discovery:: A comparison between in silico and crystal structures of the β2-adrenergic receptor [J].
Costanzi, Stefano .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) :2907-2914
[39]   Adenosine Receptor Modeling: What Does the A2A Crystal Structure Tell Us? [J].
Dal Ben, D. ;
Lambertucci, C. ;
Marucci, G. ;
Volpini, R. ;
Cristalli, G. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (10) :993-1018
[40]   Selective structure-based virtual screening for full and partial agonists of the β2 adrenergic receptor [J].
de Graaf, Chris ;
Rognan, Didier .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) :4978-4985